Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$40.9 - $45.1 $1.37 Million - $1.51 Million
-33,500 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$38.07 - $44.87 $57,105 - $67,305
1,500 Added 4.69%
33,500 $1.42 Million
Q3 2021

Nov 10, 2021

SELL
$41.23 - $45.88 $206,149 - $229,400
-5,000 Reduced 13.51%
32,000 $1.39 Million
Q2 2021

Aug 09, 2021

BUY
$38.58 - $44.24 $77,160 - $88,480
2,000 Added 5.71%
37,000 $1.58 Million
Q1 2021

May 11, 2021

BUY
$35.27 - $39.67 $352,700 - $396,700
10,000 Added 40.0%
35,000 $1.35 Million
Q4 2020

Feb 11, 2021

BUY
$33.15 - $41.97 $82,875 - $104,925
2,500 Added 11.11%
25,000 $899,000
Q3 2020

Nov 03, 2020

SELL
$34.44 - $42.23 $86,100 - $105,574
-2,500 Reduced 10.0%
22,500 $860,000
Q2 2020

Aug 04, 2020

BUY
$30.19 - $39.11 $90,570 - $117,330
3,000 Added 13.64%
25,000 $878,000
Q1 2020

May 13, 2020

BUY
$25.83 - $45.71 $112,360 - $198,838
4,350 Added 24.65%
22,000 $718,000
Q4 2019

Feb 07, 2020

BUY
$37.87 - $45.37 $157,160 - $188,285
4,150 Added 30.74%
17,650 $798,000
Q2 2019

Aug 08, 2019

BUY
$34.91 - $42.98 $471,284 - $580,230
13,500 New
13,500 $580,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Cumberland Partners LTD Portfolio

Follow Cumberland Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Cumberland Partners LTD with notifications on news.